NORTHWEST BIOTHERAPEUTICS INC - stock earnings
NWBO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -18.9 million USD | 445000 USD |
| 2023Q3 | -18.6 million USD | 406000 USD |
| 2023Q2 | -14.4 million USD | 201000 USD |
| 2023Q1 | -10.7 million USD | 880000 USD |
| 2022Q4 | -28.3 million USD | 597000 USD |
| 2022Q3 | -32.9 million USD | 206000 USD |
| 2022Q2 | -29.7 million USD | 477000 USD |
| 2022Q1 | -14.2 million USD | 403000 USD |
| 2021Q4 | 133.3 million USD | 350000 USD |
| 2021Q3 | 45.5 million USD | 350000 USD |
| 2021Q2 | 4.4 million USD | 416000 USD |
| 2021Q1 | -4.1 million USD | 239000 USD |
| 2020Q4 | -280.5 million USD | 503000 USD |
| 2020Q3 | -194.1 million USD | 216000 USD |
| 2020Q2 | -58.0 million USD | 2000 USD |
| 2020Q1 | 2.7 million USD | 570000 USD |
| 2019Q4 | 6.7 million USD | 897000 USD |
| 2019Q3 | -6.2 million USD | 593000 USD |
| 2019Q2 | 219000 USD | 581000 USD |
| 2019Q1 | -20.9 million USD | 339000 USD |
| 2018Q4 | -5.7 million USD | -451000 USD |
| 2018Q3 | 12.6 million USD | 453000 USD |
| 2018Q2 | -21.2 million USD | 278000 USD |
| 2018Q1 | -21.5 million USD | 132000 USD |
| 2017Q4 | -27.0 million USD | 32000 USD |
| 2017Q3 | -23.3 million USD | 148000 USD |
| 2017Q2 | -10.3 million USD | 88000 USD |
| 2017Q1 | -12.6 million USD | 68000 USD |
| 2016Q4 | -30.7 million USD | 71000 USD |
| 2016Q3 | -29.2 million USD | 159000 USD |
| 2016Q2 | -14.2 million USD | 157000 USD |
| 2016Q1 | -6.1 million USD | 236000 USD |
| 2015Q4 | -24.1 million USD | 863000 USD |
| 2015Q3 | 22.6 million USD | 291000 USD |
| 2015Q2 | -66.8 million USD | 391000 USD |
| 2015Q1 | -46.4 million USD | 194000 USD |
| 2014Q4 | -42.7 million USD | 872000 USD |
| 2014Q3 | -21.0 million USD | 582000 USD |
| 2014Q2 | -25.9 million USD | ? USD |
| 2014Q1 | -46.0 million USD | ? USD |
| 2013Q4 | -16.9 million USD | ? USD |
| 2013Q3 | -22.9 million USD | 400000 USD |
| 2013Q2 | -11.6 million USD | 272000 USD |
| 2013Q1 | -14.4 million USD | 137000 USD |
| 2012Q4 | -30.5 million USD | 322000 USD |
| 2012Q3 | -16.5 million USD | 120000 USD |
| 2012Q2 | -10.2 million USD | 330000 USD |
| 2012Q1 | -10.2 million USD | ? USD |
| 2011Q3 | 482000 USD | 10000 USD |
| 2011Q2 | -12.3 million USD | ? USD |
| 2010Q3 | ? USD | 10000 USD |
| 2009Q3 | ? USD | 10000 USD |
| 2008Q3 | ? USD | 10000 USD |
| 2007Q3 | ? USD | 10000 USD |
| 2006Q3 | ? USD | 80000 USD |
| 2006Q2 | 6.4 million USD | ? USD |
| 2005Q4 | ? USD | 14000 USD |
| 2005Q3 | ? USD | 15000 USD |
| 2005Q2 | ? USD | 8000 USD |
| 2005Q1 | ? USD | 87000 USD |
| 2004Q4 | ? USD | 56000 USD |
| 2004Q3 | ? USD | 91000 USD |
| 2004Q2 | ? USD | 116000 USD |
| 2004Q1 | ? USD | 127000 USD |
| 2003Q4 | ? USD | 128000 USD |
| 2003Q3 | ? USD | 145000 USD |
| 2003Q2 | ? USD | 187000 USD |
| 2003Q1 | ? USD | 69000 USD |
| 2002Q2 | ? USD | 6000 USD |
| 2002Q1 | ? USD | 3000 USD |
| 2001Q4 | ? USD | 55000 USD |
| 2001Q3 | ? USD | 14000 USD |
| 2001Q2 | ? USD | 16000 USD |
| 2001Q1 | ? USD | 44000 USD |
| 2000Q4 | ? USD | 156000 USD |
NWBO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -62.6 million USD | 1.9 million USD |
| 2022 | -105.0 million USD | 1.7 million USD |
| 2021 | 179.1 million USD | 1.0 million USD |
| 2020 | -529.8 million USD | 1.3 million USD |
| 2019 | -20.3 million USD | 2.4 million USD |
| 2018 | -35.8 million USD | 412000 USD |
| 2017 | -73.1 million USD | 336000 USD |
| 2016 | -80.2 million USD | 623000 USD |
| 2015 | -114.7 million USD | 1.7 million USD |
| 2014 | -135.6 million USD | 1.5 million USD |
| 2013 | -65.8 million USD | 809000 USD |
| 2012 | -67.3 million USD | 772000 USD |
| 2011 | -32.8 million USD | 10000 USD |
| 2010 | ? USD | 10000 USD |
| 2009 | ? USD | 10000 USD |
| 2008 | ? USD | 10000 USD |
| 2007 | ? USD | 10000 USD |
| 2006 | ? USD | 80000 USD |
| 2005 | ? USD | 124000 USD |
| 2004 | ? USD | 390000 USD |
| 2003 | ? USD | 529000 USD |
| 2002 | ? USD | 9000 USD |
| 2001 | ? USD | 129000 USD |
| 2000 | ? USD | 156000 USD |
NWBO
Price: $0.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -9.93
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 1.3 million
Ebitda: -69.1 millionMarket Capitalization: 654.5 million